Home / Health / Jersey Trials Tech for Better Heart Care
Jersey Trials Tech for Better Heart Care
2 Jul
Summary
- Jersey selected for clinical trial of new patient care technology.
- HFpEF patients to test if injected iron improves heart symptoms.
- Smart ring and thigh patch will monitor treatment effectiveness over 14 weeks.
Jersey is at the forefront of medical innovation, chosen to conduct a vital clinical trial testing novel technology designed to improve patient outcomes. The study specifically targets individuals suffering from Heart Failure with Preserved Ejection Fraction (HFpEF).
Participants in this trial will evaluate the efficacy of iron injected intravenously in alleviating heart failure symptoms and enhancing their ability to exercise. Over a 14-week period, patients will utilize wearable devices, including a smart ring and a thigh patch, to meticulously analyze the treatment's impact.
Dr. Aaron Henry from Jersey Hospital's cardiology department expressed enthusiasm, highlighting the importance of embracing the latest technological advancements in healthcare. This initiative underscores a commitment to advancing medical care through cutting-edge research and technology.
